Literature DB >> 22222123

What is the clinical value of lung volumes?

Gregg L Ruppel1.   

Abstract

Lung volumes are considered part of a complete pulmonary function test, but their value for enhancing clinical decision making is unknown. Unlike spirometry and diffusing capacity of the lung for carbon monoxide (D(LCO)), which do contribute to confirming or excluding a diagnosis, there are few clear indications when lung volumes are discriminatory. Confirming "restriction" when vital capacity (VC) or FVC is reduced is perhaps the most important. A restrictive pattern can have many etiologies, and clinicians often use VC or FVC as a primary index of lung volume. This makes "physiologic" sense because, in healthy subjects, and in patients with true restriction, VC comprises most of the total lung capacity (TLC). Mixed obstruction-restriction and the nonspecific pattern (ie, reduced FVC and FEV(1), normal FEV(1)/FVC and TLC) require measuring TLC to confirm the underlying physiology. In obesity, VC and TLC may remain within normal limits, but functional residual capacity (FRC) can exponentially decrease. Increased lung volumes, particularly residual volume (RV), are commonly observed in airway obstruction. TLC may be normal, but is frequently increased in the late stages of COPD. Hyperinflation and air-trapping are terms commonly used to reflect these changes, but are not well standardized. The variability of lung volumes related to degree of obstruction suggests that measuring gas-trapping may be needed to monitor therapy. Changes in inspiratory capacity, RV, or FRC may be important gauges of response to bronchodilators or other hyperinflation-reducing therapies. How lung volumes are measured may be important, especially in patients who have moderate or severe airway obstruction. Body plethysmography is often considered more accurate than gas dilution methods in the presence of obstruction. However, the differences between techniques are not completely understood. Newer approaches such as computed tomography, although not suitable for routine testing, may help to delineate the true underlying physiology.

Entities:  

Mesh:

Year:  2012        PMID: 22222123     DOI: 10.4187/respcare.01374

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  16 in total

1.  Sleep-Disordered Breathing in Patients with Polycystic Liver and Kidney Disease Referred for Transcatheter Arterial Embolization.

Authors:  Keiichi Sumida; Junichi Hoshino; Tatsuya Suwabe; Takatoshi Kasai; Noriko Hayami; Koki Mise; Masahiro Kawada; Aya Imafuku; Rikako Hiramatsu; Eiko Hasegawa; Masayuki Yamanouchi; Naoki Sawa; Koji Narui; Kenmei Takaichi; Yoshifumi Ubara
Journal:  Clin J Am Soc Nephrol       Date:  2015-03-30       Impact factor: 8.237

2.  Air pollution enhance the progression of restrictive lung function impairment and diffusion capacity reduction: an elderly cohort study.

Authors:  Chi-Hsien Chen; Chih-Da Wu; Ya Ling Lee; Kang-Yun Lee; Wen-Yi Lin; Jih-I Yeh; Hsing-Chun Chen; Yue-Liang Leon Guo
Journal:  Respir Res       Date:  2022-07-14

3.  Diffusing capacity in normal-for-age spirometry and spirometric impairments, using reference equations from the global lung function initiative.

Authors:  Carlos A Vaz Fragoso; Carolyn L Rochester; Gail J McAvay; Lynne Iannone; Linda S Leo-Summers
Journal:  Respir Med       Date:  2020-05-21       Impact factor: 3.415

4.  The effect of time-of-day and chest physiotherapy on multiple breath washout measures in children with clinically stable cystic fibrosis.

Authors:  Christian Voldby; Kent Green; Susanne Rosthøj; Thomas Kongstad; Lue Philipsen; Frederik Buchvald; Marianne Skov; Tania Pressler; Per Gustafsson; Kim G Nielsen
Journal:  PLoS One       Date:  2018-01-10       Impact factor: 3.240

Review 5.  The physiological basis and clinical significance of lung volume measurements.

Authors:  Mohamed Faisal Lutfi
Journal:  Multidiscip Respir Med       Date:  2017-02-09

6.  Prolonged use of noninvasive positive pressure ventilation after extubation among patients in the intensive care unit following cardiac surgery: The predictors and its impact on patient outcome.

Authors:  Pei-Ku Chen; Chun-Che Shih; Fang-Chi Lin; Diahn-Warng Perng; Kun-Ta Chou; Yu Ru Kou; Hsin-Kuo Ko
Journal:  Sci Rep       Date:  2019-07-02       Impact factor: 4.379

7.  Approaches to the assessment of severe asthma: barriers and strategies.

Authors:  Eleanor C Majellano; Vanessa L Clark; Natasha A Winter; Peter G Gibson; Vanessa M McDonald
Journal:  J Asthma Allergy       Date:  2019-08-23

8.  Lung Deflation and Cardiovascular Structure and Function in Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial.

Authors:  Ian S Stone; Neil C Barnes; Wai-Yee James; Dawn Midwinter; Redha Boubertakh; Richard Follows; Leonette John; Steffen E Petersen
Journal:  Am J Respir Crit Care Med       Date:  2016-04-01       Impact factor: 21.405

Review 9.  Airflow obstruction: is it asthma or is it COPD?

Authors:  Paola Rogliani; Josuel Ora; Ermanno Puxeddu; Mario Cazzola
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-11-30

Review 10.  Multiple Stressor Effects of Radon and Phthalates in Children: Background Information and Future Research.

Authors:  W S Kwan; D Nikezic; Vellaisamy A L Roy; K N Yu
Journal:  Int J Environ Res Public Health       Date:  2020-04-22       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.